Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 234

1.

Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer.

Venderink W, van der Leest M, van Luijtelaar A, van de Ven WJM, Fütterer JJ, Sedelaar JPM, Huisman HJ.

World J Urol. 2017 Dec;35(12):1849-1855. doi: 10.1007/s00345-017-2085-6. Epub 2017 Sep 4.

2.

PLAG1 deficiency impairs spermatogenesis and sperm motility in mice.

Juma AR, Grommen SVH, O'Bryan MK, O'Connor AE, Merriner DJ, Hall NE, Doyle SR, Damdimopoulou PE, Barriga D, Hart AH, Van de Ven WJM, De Groef B.

Sci Rep. 2017 Jul 13;7(1):5317. doi: 10.1038/s41598-017-05676-4.

3.

Synthesis and Characterization of Curcumin-Functionalized HP-β-CD-Modified GoldMag Nanoparticles as Drug Delivery Agents.

Lian T, Peng M, Vermorken AJ, Jin Y, Luo Z, Van de Ven WJ, Wan Y, Hou P, Cui Y.

J Nanosci Nanotechnol. 2016 Jun;16(6):6258-64.

PMID:
27427699
4.

Visibility of prostate cancer on transrectal ultrasound during fusion with multiparametric magnetic resonance imaging for biopsy.

van de Ven WJ, Sedelaar JP, van der Leest MM, Hulsbergen-van de Kaa CA, Barentsz JO, Fütterer JJ, Huisman HJ.

Clin Imaging. 2016 Jul-Aug;40(4):745-50. doi: 10.1016/j.clinimag.2016.02.005. Epub 2016 Feb 6.

PMID:
27317220
5.

MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience.

van de Ven WJ, Venderink W, Sedelaar JP, Veltman J, Barentsz JO, Fütterer JJ, Cornel EB, Huisman HJ.

Int Urol Nephrol. 2016 Jul;48(7):1037-45. doi: 10.1007/s11255-016-1283-2. Epub 2016 Apr 11.

6.

Emerging role of PLAG1 as a regulator of growth and reproduction.

Juma AR, Damdimopoulou PE, Grommen SV, Van de Ven WJ, De Groef B.

J Endocrinol. 2016 Feb;228(2):R45-56. doi: 10.1530/JOE-15-0449. Epub 2015 Nov 17. Review.

PMID:
26577933
7.

Biomechanical modeling constrained surface-based image registration for prostate MR guided TRUS biopsy.

van de Ven WJ, Hu Y, Barentsz JO, Karssemeijer N, Barratt D, Huisman HJ.

Med Phys. 2015 May;42(5):2470-81. doi: 10.1118/1.4917481.

PMID:
25979040
8.

Prostate cancer: MRI/US-guided biopsy--a viable alternative to TRUS-guidance.

van de Ven WJ, Barentsz JO.

Nat Rev Urol. 2013 Oct;10(10):559-60. doi: 10.1038/nrurol.2013.179. Epub 2013 Aug 13. No abstract available.

PMID:
23938941
9.

Curcumin affects proprotein convertase activity: elucidation of the molecular and subcellular mechanism.

Zhu J, Bultynck G, Luyten T, Parys JB, Creemers JW, Van de Ven WJ, Vermorken AJ.

Biochim Biophys Acta. 2013 Aug;1833(8):1924-35. doi: 10.1016/j.bbamcr.2013.04.002. Epub 2013 Apr 10.

10.

Polyphenols can inhibit furin in vitro as a result of the reactivity of their auto-oxidation products to proteins.

Zhu J, Van de Ven WJ, Verbiest T, Koeckelberghs G, Chen C, Cui Y, Vermorken AJ.

Curr Med Chem. 2013 Feb 1;20(6):840-50.

PMID:
23231348
11.

Simulated required accuracy of image registration tools for targeting high-grade cancer components with prostate biopsies.

van de Ven WJ, Hulsbergen-van de Kaa CA, Hambrock T, Barentsz JO, Huisman HJ.

Eur Radiol. 2013 May;23(5):1401-7. doi: 10.1007/s00330-012-2701-1. Epub 2012 Nov 9.

PMID:
23138386
12.

A novel magnetic nanoparticle drug carrier for enhanced cancer chemotherapy.

Chao X, Zhang Z, Guo L, Zhu J, Peng M, Vermorken AJ, Van de Ven WJ, Chen C, Cui Y.

PLoS One. 2012;7(10):e40388. doi: 10.1371/journal.pone.0040388. Epub 2012 Oct 8.

13.

Generation and characterization of non-competitive furin-inhibiting nanobodies.

Zhu J, Declercq J, Roucourt B, Ghassabeh GH, Meulemans S, Kinne J, David G, Vermorken AJ, Van de Ven WJ, Lindberg I, Muyldermans S, Creemers JW.

Biochem J. 2012 Nov 15;448(1):73-82. doi: 10.1042/BJ20120537.

14.

Comment on: Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin: a randomized, double-blind placebo-controlled crossover 4g study and an open-label 8g extension study.

Vermorken AJ, Zhu J, Van de Ven WJ, Andrès E.

Am J Hematol. 2012 Oct;87(10):E80. doi: 10.1002/ajh.23276. Epub 2012 Jun 20. No abstract available.

15.

Limitations of inhibitory activities of polyphenols on furin-mediated substrate processing.

Zhu J, Declercq J, Creemers JW, Chen C, Cui Y, Van de Ven WJ, Vermorken AJ.

Curr Med Chem. 2012;19(21):3641-50. Review.

PMID:
22716122
16.

Curcumin for monoclonal gammopathies. What can we hope for, what should we fear?

Vermorken AJ, Zhu J, Van de Ven WJ, Andrès E.

Crit Rev Oncol Hematol. 2012 Dec;84(3):350-60. doi: 10.1016/j.critrevonc.2012.04.005. Epub 2012 May 19. Review.

PMID:
22613672
17.

Pdx1- and Ngn3-Cre-mediated PLAG1 expression in the pancreas leads to endocrine hormone imbalances that affect glucose metabolism.

Declercq J, Kumar A, Gysemans C, Di Pietro C, Schraenen A, Chintinne M, Lemaire K, Van Lommel L, Van De Casteele M, Heimberg H, Pipeleers D, Schuit FC, Mathieu C, Ectors N, Van de Ven WJ, Verfaillie CM.

Cell Transplant. 2011;20(8):1285-97. doi: 10.3727/096368910X550242. Epub 2011 Feb 3.

PMID:
21294959
18.

Increased beta-cell mass by islet transplantation and PLAG1 overexpression causes hyperinsulinemic normoglycemia and hepatic insulin resistance in mice.

Declercq J, Kumar A, Van Diepen JA, Vroegrijk IO, Gysemans C, Di Pietro C, Voshol PJ, Mathieu C, Ectors N, Van de Ven WJ, Verfaillie CM.

Diabetes. 2010 Aug;59(8):1957-65. doi: 10.2337/db09-1446. Epub 2010 Jun 3.

19.

The alpha-motoneuron pool as transmitter of rhythmicities in cortical motor drive.

Stegeman DF, van de Ven WJ, van Elswijk GA, Oostenveld R, Kleine BU.

Clin Neurophysiol. 2010 Oct;121(10):1633-42. doi: 10.1016/j.clinph.2010.03.052.

PMID:
20434397
20.

Is curcumin for monoclonal gammopathy of undetermined significance without risk?--letter.

Vermorken AJ, Zhu J, Van de Ven WJ.

Clin Cancer Res. 2010 Apr 1;16(7):2225. doi: 10.1158/1078-0432.CCR-10-0218. Epub 2010 Mar 23. No abstract available.

21.

Curcumin for the prevention of progression in monoclonal gammopathy of undetermined significance: A word of caution.

Vermorken AJ, Zhu J, VAN DE Ven WJ, Cui Y, Fryns JP.

Exp Ther Med. 2010 Mar;1(2):265-269. Epub 2010 Mar 1.

22.

SCAMP5, NBEA and AMISYN: three candidate genes for autism involved in secretion of large dense-core vesicles.

Castermans D, Volders K, Crepel A, Backx L, De Vos R, Freson K, Meulemans S, Vermeesch JR, Schrander-Stumpel CT, De Rijk P, Del-Favero J, Van Geet C, Van De Ven WJ, Steyaert JG, Devriendt K, Creemers JW.

Hum Mol Genet. 2010 Apr 1;19(7):1368-78. doi: 10.1093/hmg/ddq013. Epub 2010 Jan 12.

PMID:
20071347
23.

Targeted disruption of the mouse Lipoma Preferred Partner gene.

Vervenne HB, Crombez KR, Delvaux EL, Janssens V, Van de Ven WJ, Petit MM.

Biochem Biophys Res Commun. 2009 Feb 6;379(2):368-73. doi: 10.1016/j.bbrc.2008.12.074. Epub 2008 Dec 26.

PMID:
19111675
24.

The human pseudoxanthoma elasticum gene ABCC6 is transcriptionally regulated by PLAG family transcription factors.

Ratajewski M, Van de Ven WJ, Bartosz G, Pulaski L.

Hum Genet. 2008 Dec;124(5):451-63. doi: 10.1007/s00439-008-0570-0. Epub 2008 Oct 12.

PMID:
18850323
25.

Role of furin in granular acidification in the endocrine pancreas: identification of the V-ATPase subunit Ac45 as a candidate substrate.

Louagie E, Taylor NA, Flamez D, Roebroek AJ, Bright NA, Meulemans S, Quintens R, Herrera PL, Schuit F, Van de Ven WJ, Creemers JW.

Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12319-24. doi: 10.1073/pnas.0800340105. Epub 2008 Aug 19.

26.

Adenomyoepitheliomatous lesions of the mammary glands in transgenic mice with targeted PLAG1 overexpression.

Declercq J, Skaland I, Van Dyck F, Janssen EA, Baak JP, Drijkoningen M, Van de Ven WJ.

Int J Cancer. 2008 Oct 1;123(7):1593-600. doi: 10.1002/ijc.23586.

27.

Lpp is involved in Wnt/PCP signaling and acts together with Scrib to mediate convergence and extension movements during zebrafish gastrulation.

Vervenne HB, Crombez KR, Lambaerts K, Carvalho L, Köppen M, Heisenberg CP, Van de Ven WJ, Petit MM.

Dev Biol. 2008 Aug 1;320(1):267-77. doi: 10.1016/j.ydbio.2008.05.529. Epub 2008 May 20.

28.

Upregulation of Igf and Wnt signalling associated genes in pleomorphic adenomas of the salivary glands in PLAG1 transgenic mice.

Declercq J, Van Dyck F, Van Damme B, Van de Ven WJ.

Int J Oncol. 2008 May;32(5):1041-7.

PMID:
18425330
29.

Position effect leading to haploinsufficiency in a mosaic ring chromosome 14 in a boy with autism.

Castermans D, Thienpont B, Volders K, Crepel A, Vermeesch JR, Schrander-Stumpel CT, Van de Ven WJ, Steyaert JG, Creemers JW, Devriendt K.

Eur J Hum Genet. 2008 Oct;16(10):1187-92. doi: 10.1038/ejhg.2008.71. Epub 2008 Apr 16.

30.

The HMGA proteins: a myriad of functions (Review).

Cleynen I, Van de Ven WJ.

Int J Oncol. 2008 Feb;32(2):289-305. Review.

PMID:
18202751
31.

aP2-Cre-mediated expression activation of an oncogenic PLAG1 transgene results in cavernous angiomatosis in mice.

Van Dyck F, Scroyen I, Declercq J, Sciot R, Kahn B, Lijnen R, Van de Ven WJ.

Int J Oncol. 2008 Jan;32(1):33-40.

PMID:
18097540
32.

Loss of the PlagL2 transcription factor affects lacteal uptake of chylomicrons.

Van Dyck F, Braem CV, Chen Z, Declercq J, Deckers R, Kim BM, Ito S, Wu MK, Cohen DE, Dewerchin M, Derua R, Waelkens E, Fiette L, Roebroek A, Schuit F, Van de Ven WJ, Shivdasani RA.

Cell Metab. 2007 Nov;6(5):406-13.

33.

HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB.

Cleynen I, Brants JR, Peeters K, Deckers R, Debiec-Rychter M, Sciot R, Van de Ven WJ, Petit MM.

Mol Cancer Res. 2007 Apr;5(4):363-72.

34.

PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review).

Van Dyck F, Declercq J, Braem CV, Van de Ven WJ.

Int J Oncol. 2007 Apr;30(4):765-74. Review.

PMID:
17332914
35.

Identification and characterization of the TRIP8 and REEP3 genes on chromosome 10q21.3 as novel candidate genes for autism.

Castermans D, Vermeesch JR, Fryns JP, Steyaert JG, Van de Ven WJ, Creemers JW, Devriendt K.

Eur J Hum Genet. 2007 Apr;15(4):422-31. Epub 2007 Feb 7.

36.

Sesn1 is a novel gene for left-right asymmetry and mediating nodal signaling.

Peeters H, Voz ML, Verschueren K, De Cat B, Pendeville H, Thienpont B, Schellens A, Belmont JW, David G, Van De Ven WJ, Fryns JP, Gewillig M, Huylebroeck D, Peers B, Devriendt K.

Hum Mol Genet. 2006 Nov 15;15(22):3369-77. Epub 2006 Oct 12.

37.

The LIM domain protein LPP is a coactivator for the ETS domain transcription factor PEA3.

Guo B, Sallis RE, Greenall A, Petit MM, Jansen E, Young L, Van de Ven WJ, Sharrocks AD.

Mol Cell Biol. 2006 Jun;26(12):4529-38.

38.

The tumor suppressor Scrib selectively interacts with specific members of the zyxin family of proteins.

Petit MM, Crombez KR, Vervenne HB, Weyns N, Van de Ven WJ.

FEBS Lett. 2005 Sep 12;579(22):5061-8.

39.

Salivary gland tumors in transgenic mice with targeted PLAG1 proto-oncogene overexpression.

Declercq J, Van Dyck F, Braem CV, Van Valckenborgh IC, Voz M, Wassef M, Schoonjans L, Van Damme B, Fiette L, Van de Ven WJ.

Cancer Res. 2005 Jun 1;65(11):4544-53.

40.

Transactivation functions of the tumor-specific HMGA2/LPP fusion protein are augmented by wild-type HMGA2.

Crombez KR, Vanoirbeek EM, Van de Ven WJ, Petit MM.

Mol Cancer Res. 2005 Feb;3(2):63-70.

41.

Carpal and tarsal synostoses and transverse reduction defects of the toes in two brothers heterozygous for a double de novo NOGGIN mutation.

Debeer P, Huysmans C, Van de Ven WJ, Fryns JP, Devriendt K.

Am J Med Genet A. 2005 Apr 30;134(3):318-20.

PMID:
15736221
42.

The tumor suppressor Scrib interacts with the zyxin-related protein LPP, which shuttles between cell adhesion sites and the nucleus.

Petit MM, Meulemans SM, Alen P, Ayoubi TA, Jansen E, Van de Ven WJ.

BMC Cell Biol. 2005 Jan 13;6(1):1.

43.

Targeted disruption of the murine Plag1 proto-oncogene causes growth retardation and reduced fertility.

Hensen K, Braem C, Declercq J, Van Dyck F, Dewerchin M, Fiette L, Denef C, Van de Ven WJ.

Dev Growth Differ. 2004 Oct;46(5):459-70.

PMID:
15606491
44.

Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11.

Landrette SF, Kuo YH, Hensen K, Barjesteh van Waalwijk van Doorn-Khosrovani S, Perrat PN, Van de Ven WJ, Delwel R, Castilla LH.

Blood. 2005 Apr 1;105(7):2900-7. Epub 2004 Dec 7.

PMID:
15585652
45.

Limited redundancy of the proprotein convertase furin in mouse liver.

Roebroek AJ, Taylor NA, Louagie E, Pauli I, Smeijers L, Snellinx A, Lauwers A, Van de Ven WJ, Hartmann D, Creemers JW.

J Biol Chem. 2004 Dec 17;279(51):53442-50. Epub 2004 Oct 7.

46.

A novel NOG mutation Pro37Arg in a family with tarsal and carpal synostoses.

Debeer P, Fryns JP, Devriendt K, Baten E, Huysmans C, Van de Ven WJ.

Am J Med Genet A. 2004 Aug 1;128A(4):439-40. No abstract available.

PMID:
15264296
47.

Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2.

Brants JR, Ayoubi TA, Chada K, Marchal K, Van de Ven WJ, Petit MM.

FEBS Lett. 2004 Jul 2;569(1-3):277-83.

48.

Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation.

Van Dyck F, Delvaux EL, Van de Ven WJ, Chavez MV.

J Biol Chem. 2004 Aug 20;279(34):36121-31. Epub 2004 Jun 18.

49.

PLAG proteins: how they influence apoptosis and cell proliferation.

Declercq J, Hensen K, Van De Ven WJ, Chavez M.

Ann N Y Acad Sci. 2003 Dec;1010:264-5.

PMID:
15033731
50.

Bilateral complete radioulnar synostosis associated with ectrodactyly and sensorineural hearing loss: a variant of SHFM1.

Debeer P, Vandenbossche L, de Ravel TJ, Desloovere C, De Smet L, Huysmans C, Thoelen R, Vermeesch J, Van de Ven WJ, Fryns JP.

Clin Genet. 2004 Feb;65(2):153-5. No abstract available. Erratum in: Clin Genet. 2004 Apr;65(4):345.

PMID:
14984476

Supplemental Content

Loading ...
Support Center